Anti-CD20 Therapy



Pharmacology


Adverse Effects

Cardiovascular Adverse Effects

Cardiac Arrest (see Cardiac Arrest, [[Cardiac Arrest]])

Cytokine Release Syndrome (see Cytokine Release Syndrome, [[Cytokine Release Syndrome]])

Infectious Adverse Effects

Babesiosis (see Babesiosis, [[Babesiosis]])

Cytomegalovirus (CMV) (see Cytomegalovirus, [[Cytomegalovirus]])

Enterovirus Meningioencephalitis (see Enteroviruses, [[Enteroviruses]])

Hepatitis B Reactivation (see Hepatitis B Virus, [[Hepatitis B Virus]])

Infection

Mycobacterium Avium Complex (MAC) (see Mycobacterium Avium Complex, [[Mycobacterium Avium Complex]])

Mycobacterium Kansasii (see Mycobacterium Kansasii, [[Mycobacterium Kansasii]])

Parvovirus B19 with Pure Red Cell Aplasia (see Parvovirus B19, [[Parvovirus B19]])

Pneumocytsis Jirovecii Pneumonia (PCP) (see Pneumocystis Jirovecii, [[Pneumocystis Jirovecii]])

Progressive Multifocal Encephalopathy (PML) (see Progressive Multifocal Leukoencephalopathy, [[Progressive Multifocal Leukoencephalopathy]])

West Nile Virus (see Encephalitis, [[Encephalitis]])

Neurologic Adverse Effects

Posterior Reversible Encephalopathy Syndrome (PRES) (see Posterior Reversible Encephalopathy Syndrome, [[Posterior Reversible Encephalopathy Syndrome]])

Pulmonary Adverse Effects

Cytokine Release Syndrome (see Cytokine Release Syndrome, [[Cytokine Release Syndrome]])

Cytomegalovirus (CMV) (see Cytomegalovirus, [[Cytomegalovirus]])

Diffuse Alveolar Hemorrhage (DAH) (see Diffuse Alveolar Hemorrhage, [[Diffuse Alveolar Hemorrhage]])

Interstitial Lung Disease (ILD) (see Interstitial Lung Disease, [[Interstitial Lung Disease]])

Pneumocytsis Jirovecii Pneumonia (PCP) (see Pneumocystis Jirovecii, [[Pneumocystis Jirovecii]])

Mycobacterium Avium Complex (MAC) (see Mycobacterium Avium Complex, [[Mycobacterium Avium Complex]])

Mycobacterium Kansasii (see Mycobacterium Kansasii, [[Mycobacterium Kansasii]])

Other Adverse Effects

Tumor Lysis Syndrome (see Tumor Lysis Syndrome, [[Tumor Lysis Syndrome]])


References